InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,539.37
(
0.52%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

chuckanutman

Send PM Follow Ignore
Followers 43
Posts 5405
Boards Moderated 0
Alias Born 03/05/2010

chuckanutman

Re: None

Tuesday, 12/01/2015 8:25:58 AM

Tuesday, December 01, 2015 8:25:58 AM

Post# of 92948
With OCATA's NED "no-embryo-destroyed" method, will China make a bid?

Do we see a connection here? PFE AGN Roche and REGN have an interest in eyesight maintenance and treatment.

http://www.iddst.com/iddst2015/ScientificProgram9.asp
Title: Moving Pluripotent Stem Cell Therapies to the Clinic: Retinal Cells for the Treatment of Eye Diseases
Dr. Shi-Jiang (John) Lu, Senior Director of Research, Ocata Therapeutics, Inc., USA

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up